Low prevalence of latently Epstein-Barr virus-infected cells in chronic gastritis

Microscopy Research and Technique

Volumn 53, Issue 6, 2001, Pages 409-413

  Hungermann, Daniela ^a   Müller, Susanna ^b   Spieker, Tilmann ^c   Lisner, Renate ^b   Niedobitek, Gerald ^b   Herbst, Hermann ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Chronic gastritis; Epstein Barr virus; Gastric carcinoma; Herpesvirus 4; In situ hybridization

Indexed keywords

CYTOLOGY; LYMPHOCYTES; PROBES; RADIOACTIVITY; VIRUSES;

CELL-BE; CELL/B.E; CELL/BE; CHRONIC GASTRITIS; CONDITION; EPSTEIN-BARR VIRUS; GASTRIC CARCINOMA; HERPESVIRUS 4; IN-SITU HYBRIDIZATION; VIRUS-INFECTED CELLS;

BIOPSY;

RNA;

ARTICLE; CARCINOGENESIS; CHRONIC GASTRITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GASTROINTESTINAL TRACT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; INFLAMMATION; LATENT PERIOD; LYMPHOCYTE; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH CARCINOMA; STOMACH MUCOSA; STROMA CELL;

EID: 0035877060     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.1109     Document Type: Article

References (31)

1. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. 1998. EBV persistence in memory B cells in vivo. Immunity 9:395-404.
2. Bamford KB, Fan X, Erbst PB. 1998. Lymphocytes in human gastric mucosa during helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114:482-492.
3. Baumann MA, Paul CC. 1992. Interleukin-5 is an autocrine growth factor for Epstein-Barr virus transformed B lymphocytes. Blood 79:1763-1767.
4. Christ AD, Stevens AC, Koeppen H, Walsh S, Omata F, Devergne O, Birkenbach M, Blumberg RS. 1998. An interleukin-12 related cytokine is upregulated in ulcerative colitis, but not in Crohn's disease. Gastroenterology 115:307-313.
5. D'Elios MM, Manghetti M, DeCarli M, Costa F, Baldari CT, Burroni D, Telfort JL, Romagnani S, Del Prete G. 1997. T helper effector cells specific for Helicobacter pylori in the gastric antrum of patients with gastric ulcer disease. J Immunol 158:962-967.
6. Dixon MF, Genta RM, Yardley JH, Correa P. 1996. Classification and grading of gastritis: the updated Sydney classification. Am J Surg Pathol 20:1161-1181.
7. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. 1991. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J Immunol 141:3444-3451.
8. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-α, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157:1261-1270.
9. Hatz RA, Meimarakis G, Enders G. 1996. Characterisation of lymphocytic infiltrates in Helicobacter-associated gastritis. Scand J Gastroenterol 31:222-228.
10. Herbst H. 1996. Epstein-Barr virus in Hodgkin's disease: Semin Cancer Biol 7:183-189.
11. IARC. 1994. Schistosomes, liver flukes and Helicobacter pylori. In: IARC Monographs on the evaluation of carcinogenic risks to humans, vol. 61. Lyon, France. p 177-240.
12. Imai S, Koizumi S, Sugiura M, Tokunaga Y, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T. 1994. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 19:9131-9135.
13. Isaacson PG, Norton AJ. 1994. Extranodal lymphomas. Edinburgh: Churchill-Livingston. p 15-67.
14. Karajannis M, Hummel M, Anagnostopoulos J, Stein H. 1997. Strict lymphotropism of Epstein-Barr virus during acute infectious mononucleosis in nonimmunocompromised individuals. Blood 89:2856-2862.
15. Mosmann TR. 1994. Properties and function of interleukin-10. Adv Immunol 56:1-26.
16. Niedobitek G, Herbst H, Young LS, Brooks L, Masucci MG, Crocker J, Rickinson AB, Stein H. 1992. Patterns of Epstein-Barr virus infection in non neoplastic lymphoid tissue. Blood 79:2520-2526.
17. Niedobitek G, Agathanggelou A, Nicholls JM. 1996. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumor cell phenotype, and the role of the lymphoid stroma. Semin Cancer Biol 7:165-174.
18. Niedobitek G, Agathangellou A, Herbst H, Whitehead L, Wright DH, Young LS. 1997. Epstein-Barr virus infection in infectious mononucleosis: virus latency, replication and phenotype of Epstein-Barr virus infected cells. J Pathol 182:51-159.
19. Niedobitek G, Lisner R, Swoboda B, Rooney N, Fassbender HG, Kirchner T, Aigner T, Herbst H. 2000. Lack of evidence for an involvement of Epstein-Barr virus infection of synovial membranes in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 43: 151-154.
20. Nyren O. 1998. Is Helicobacter pylori really the cause of gastric cancer? Semin Cancer Biol 8:275-283.
21. Osato T, Imai S. 1996. Epstein-Barr virus and gastric carcinomas. Semin Cancer Biol 7:175-182.
22. Parronchi P, Romagnani P, Annunziato F, Sampognaro A, Becchio A, Giannarini L, Maggi E, Pupilli C, Tonelli F, Romagnani S. 1996. Type 1 helper cell predominance and interleukine 12 expression in the gut of patients with Crohn's disease. Am J Pathol 150:823-832.
23. Parsonnet J, Friedman GD, Vandesteen, DP, Chang Y, Vogelman JH, Orentreich N, Sibley EK. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127-1131.
24. Paul WE. 1991. Interleukin 4: a prototypic immunoregulatory lymphokine. Blood 77:1859-1870.
25. Rickinson AB, Kieff E. 1996. Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology, 2nd ed, vol. 2. Philadelphia: Lipincott-Raven. p 2397-2446.
26. Rowlands DC, Ito M, Mangham DC, Reynolds G, Herbst H, Hallessey MT, Fielding JWL, Newbold KM, Jones EL, Young LS, Niedobitek G. 1993. Epstein-Barr virus and gastric carcinomas: rare association of the virus with gastric adenocarcinomas. Br J Cancer 68: 1014-1019.
27. Schafer LW, Larson DE, Melton LJ, Higgins JA, Zinsmeister AR. 1985. Risk of development of gastric carcinoma in patients with pernicious anemia: a population-based study in Rochester, Minnesota. Mayo Clin Proc 60:444.
28. Sher A, Gazzinelli RT, Oswald JP, Clerici M, Kullberg M, Pearce EJ, Berzofsky JA, Mosmann TR, James SL, Morse HC. 1992. Role of T cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev 127:183-204.
29. Spieker T, Herbst H. 2000. Distribution and phenotype of Epstein-Barr virus infected cells in inflammatory bowel disease. Am J Pathol 157:51-57.
30. Tosato G, Tanner J, Jones KD, Revel M, Pike SE. 1990. Identification of interleukin-6 as a autocrine growth factor for Epstein-Barr virus immortalized B-cells. J Virol 64:3033-3041.
31. Yanai H, Takada K, Shimizu N, Mizugaki Y, Tada M, Okita K. 1997. Epstein-Barr virus infection in non-carcinomatous gastric epithelium. J Pathol 183:293-298.